Roche MS drug recommended by EMA

A new monoclonal antibody treatment for multiple sclerosis (MS) has been recommended for approval by the European Medicines Agency following clinical studies that showed significant benefits for patients with both relapsing and primary progressive forms of the disease.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom